Clinical Research Directory
Browse clinical research sites, groups, and studies.
Anti-Müllerian Hormone in Breast Cancer Clinical Practice
Sponsor: Masaryk Memorial Cancer Institute
Summary
This study aims to evaluate serum anti-Müllerian hormone (AMH) levels and complementary hormonal parameters, including follicle-stimulating hormone (FSH), estradiol, thyroid-stimulating hormone (TSH), and free thyroxine (fT4), in women with breast cancer and healthy female controls. The study will generate preliminary real-world data on AMH and related hormonal parameters and assess the feasibility of implementing AMH testing into routine clinical practice.
Key Details
Gender
FEMALE
Age Range
20 Years - 55 Years
Study Type
OBSERVATIONAL
Enrollment
200
Start Date
2025-11-20
Completion Date
2027-12
Last Updated
2026-10-27
Healthy Volunteers
Yes
Conditions
Locations (1)
Masaryk Memorial Cancer Institute
Brno, Czechia